Generic Diflucan is an antifungal antibiotic. It is used to treat infections caused by fungus, which can invade any part of the body including the mouth, throat, esophagus, lungs, bladder, genital area and the blood. More info »
Lesions that continue to recur in the same place - Journal of the American Academy of Physician Assistants
Journal of the American Academy of Physician AssistantsLesions that continue to recur in the same placeJournal of the American Academy of Physician AssistantsThe pattern had repeated itself for at least 10 years, during which she had been otherwise healthy except for periodic vaginal yeast infections for which she took brief courses of fluconazole.
MethylGene to Present at the 14th Annual BIO CEO & Investor Conference - MarketWatch (press release)
MethylGene to Present at the 14th Annual BIO CEO & Investor ConferenceMarketWatch (press release)The Company's lead product candidates include: MGCD265, an oral Met/VEGF receptor kinase inhibitor that is in Phase 1/2 clinical trials for solid tumor cancers, and MGCD290, a fungal Hos2 inhibitor, for use in combination with fluconazole for fungal .
That which does not kill yeast makes it stronger - EurekAlert (press release)
That which does not kill yeast makes it strongerEurekAlert (press release)Yeast cells pretreated briefly with radicicol to induce genomic instability also adapted more efficiently to the presence of other drugs including fluconazole, tunicamycin, or benomyl, when compared to euploid cells.
'Panic button' could help cancer defy drugs - New Scientist
'Panic button' could help cancer defy drugsNew ScientistFor instance, in four of the five colonies that survived a dose of fluconazole, each yeast had an extra copy of chromosome 8.
MethylGene to Present at the 14th Annual BIO CEO & Investor Conference - Marketwire (press release)
MethylGene to Present at the 14th Annual BIO CEO & Investor ConferenceMarketwire (press release)The Company's lead product candidates include: MGCD265, an oral Met/VEGF receptor kinase inhibitor that is in Phase 1/2 clinical trials for solid tumor cancers, and MGCD290, a fungal Hos2 inhibitor, for use in combination with fluconazole for fungal .